Related references
Note: Only part of the references are listed.Systemic administration of 3-bromopyruvate in treating disseminated aggressive lymphoma
Niklaus G. Schaefer et al.
TRANSLATIONAL RESEARCH (2012)
Inhibition of hypoxia-inducible carbonic anhydrase-IX enhances hexokinase II inhibitor-induced hepatocellular carcinoma cell apoptosis
Su-jong Yu et al.
ACTA PHARMACOLOGICA SINICA (2011)
Regulation of Na+-coupled glucose carrier SGLT1 by human papillomavirus 18 E6 protein
Natalie Leiprecht et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Metabolic oxidative stress elicited by the copper(II) complex [Cu(isaepy)2] triggers apoptosis in SH-SY5Y cells through the induction of the AMP-activated protein kinase/p38MAPK/p53 signalling axis: evidence for a combined use with 3-bromopyruvate in neuroblastoma treatment
Giuseppe Filomeni et al.
BIOCHEMICAL JOURNAL (2011)
Expression of Transketolase like gene 1 (TKTL1) predicts disease-free survival in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy
Juliana Schwaab et al.
BMC CANCER (2011)
Somatostatin analogs for the treatment of neuroendocrine tumors
Michael D. Culler et al.
CANCER AND METASTASIS REVIEWS (2011)
2-Deoxyglucose Induces Noxa-Dependent Apoptosis in Alveolar Rhabdomyosarcoma
Silvia Ramirez-Peinado et al.
CANCER RESEARCH (2011)
Second-Generation Tyrosine Kinase Inhibitors: The Future of Frontline CML Therapy
Hagop M. Kantarjian et al.
CLINICAL CANCER RESEARCH (2011)
Pyruvate kinase type M2: A key regulator of the metabolic budget system in tumor cells
Sybille Mazurek
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2011)
Mitochondrial dysfunction and effect of antiglycolytic bromopyruvic acid in GL15 glioblastoma cells
Lara Macchioni et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2011)
Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme
Amparo Wolf et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Interfering with pH regulation in tumours as a therapeutic strategy
Dario Neri et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Targeting cancer metabolism: a therapeutic window opens
Matthew G. Vander Heiden
NATURE REVIEWS DRUG DISCOVERY (2011)
Sugar-free approaches to cancer cell killing
N. El Mjiyad et al.
ONCOGENE (2011)
Targeting GLUT1 and the Warburg Effect in Renal Cell Carcinoma by Chemical Synthetic Lethality
Denise A. Chan et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Carcinoma cells activate AMP-activated protein kinase-dependent autophagy as survival response to kaempferol-mediated energetic impairment
Giuseppe Filomeni et al.
AUTOPHAGY (2010)
3-Bromopyruvate induces necrotic cell death in sensitive melanoma cell lines
J. -Z. Qin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
The in vitro and in vivo anti-metastatic efficacy of oxythiamine and the possible mechanisms of action
Chih-Min Yang et al.
CLINICAL & EXPERIMENTAL METASTASIS (2010)
GAPDH mediates nitrosylation of nuclear proteins
Michael D. Kornberg et al.
NATURE CELL BIOLOGY (2010)
Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression
Anne Le et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Glycolysis: a bioenergetic or a survival pathway?
Juan P. Bolanos et al.
TRENDS IN BIOCHEMICAL SCIENCES (2010)
Targeting metabolic transformation for cancer therapy
Daniel A. Tennant et al.
NATURE REVIEWS CANCER (2010)
Mechanisms underlying modulation of monocarboxylate transporter 1 (MCT1) by somatostatin in human intestinal epithelial cells
Seema Saksena et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2009)
Inhibition of energy-producing pathways of HepG2 cells by 3-bromopyruvate
Ana Paula Pereira da Silva et al.
BIOCHEMICAL JOURNAL (2009)
Role of mitochondria-associated hexokinase II in cancer cell death induced by 3-bromopyruvate
Zhao Chen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2009)
Inhibition of glycolysis modulates prednisolone resistance in acute lymphoblastic leukemia cells
Esther Hulleman et al.
BLOOD (2009)
Transport by SLC5A8 With Subsequent Inhibition of Histone Deacetylase 1 (HDAC1) and HDAC3 Underlies the Antitumor Activity of 3-bromopyruvate
Muthusamy Thangaraju et al.
CANCER (2009)
Novel roles for GAPDH in cell death and carcinogenesis
A. Colell et al.
CELL DEATH AND DIFFERENTIATION (2009)
Voltage-dependent Anion Channel 1-based Peptides Interact with Hexokinase to Prevent Its Anti-apoptotic Activity
Laetitia Arzoine et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Kinetics of Transport and Phosphorylation of Glucose in Cancer Cells
Sara Rodriguez-Enriquez et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Dunyaporn Trachootham et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Targets of 3-Bromopyruvate, A New, Energy Depleting, Anticancer Agent
P. Dell'Antone
MEDICINAL CHEMISTRY (2009)
Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells
Jihye Yun et al.
SCIENCE (2009)
Hexokinase-2 bound to mitochondria: Cancer's stygian link to the Warburg effect and a pivotal target for effective therapy
Saroj P. Mathupala et al.
SEMINARS IN CANCER BIOLOGY (2009)
Sodium-coupled monocarboxylate transporters in normal tissues and in cancer
Vadivel Ganapathy et al.
AAPS JOURNAL (2008)
DNA hypermethylation and epigenetic silencing of the tumor suppressor gene, SLC5A8, in acute myeloid leukemia with the MLL partial tandem duplication
Susan P. Whitman et al.
BLOOD (2008)
Tumor cell metabolism: Cancer's Achilles' heel
Guido Kroemer et al.
CANCER CELL (2008)
Synergistic antipancreatic tumor effect by simultaneously targeting hypoxic cancer cells with HSP90 inhibitor and glycolysis inhibitor
Xianhua Cao et al.
CLINICAL CANCER RESEARCH (2008)
Role of reactive oxygen species-mediated mitochondrial dysregulation in 3-bromopyruvate induced cell death in hepatoma cells
Ji Su Kim et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2008)
A novel inhibitor of glucose uptake sensitizes cells to FAS-induced cell death
Tabitha E. Wood et al.
MOLECULAR CANCER THERAPEUTICS (2008)
3-Bromopyruvate as inhibitor of tumour cell energy metabolism and chemopotentiator of platinum drugs
Linda Strandberg Ihrlund et al.
MOLECULAR ONCOLOGY (2008)
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Heather R. Christofk et al.
NATURE (2008)
Silencing of the candidate tumor suppressor gene solute carrier family 5 member 8 (SLC5A8) in human pancreatic cancer
Jong Y. Park et al.
PANCREAS (2008)
Apoptosis-inducing antitumor efficacy of hexokinase II inhibitor in hepatocellular carcinoma
Won Kim et al.
MOLECULAR CANCER THERAPEUTICS (2007)
GAPDH and autophagy preserve survival after apoptotic cytochrome c release in the absence of caspase activation
Anna Colell et al.
CELL (2007)
GAPDH, a novel regulator of the pro-apoptotic mitochondrial membrane permeabilization
A. Tarze et al.
ONCOGENE (2007)
2-Deoxy-D-glucose combined with cisplatin, enhances cytotoxicity via metabolic oxidative stress in human head and neck cancer cells
Andreart L. Simons et al.
CANCER RESEARCH (2007)
SLC5A8 triggers tumor cell apoptosis through pyruvate-dependent inhibition of histone deacetylases
Muthusamy Thangaraju et al.
CANCER RESEARCH (2006)
Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia
Brian J. Druker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
The H+-linked monocarboxylate transporter (MCT1/SLC16A1):: A potential therapeutic target for high-risk neuroblastoma
Jun Fang et al.
MOLECULAR PHARMACOLOGY (2006)
The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1α-dependent mechanism
MS Ullah et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Targeting multidrug resistance in cancer
G Szakács et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption
I Papandreou et al.
CELL METABOLISM (2006)
Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted
S Langbein et al.
BRITISH JOURNAL OF CANCER (2006)
Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance
Valeria R. Fantin et al.
CANCER CELL (2006)
Synergistic effect of targeting mTOR by rapamycin and depleting ATP by inhibition of glycolysis in lymphoma and leukemia cells
RH Xu et al.
LEUKEMIA (2005)
Disulfide relays and phosphorylative cascades: partners in redox-mediated signaling pathways
G Filomeni et al.
CELL DEATH AND DIFFERENTIATION (2005)
Bcr-Abl expression levels determine the rate of development of resistance to imatinib mesylate in chronic myeloid leukemia
DJ Barnes et al.
CANCER RESEARCH (2005)
Optimizing cancer radiotherapy with 2-deoxy-D-glucose - Dose escalation studies in patients with glioblastoma multiforme
DH Singh et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2005)
Pyruvate kinase type M2 and its role in tumor growth and spreading
S Mazurek et al.
SEMINARS IN CANCER BIOLOGY (2005)
S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding
MR Hara et al.
NATURE CELL BIOLOGY (2005)
Shared epigenetic mechanisms in human and mouse gliomas inactivate expression of the growth suppressor SLC5A8
CB Hong et al.
CANCER RESEARCH (2005)
Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development
G Kelloff et al.
CLINICAL CANCER RESEARCH (2005)
Myricetin, quercetin and catechin-gallate inhibit glucose uptake in isolated rat adipocytes
P Strobel et al.
BIOCHEMICAL JOURNAL (2005)
Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer
ML Macheda et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2005)
Pyruvate dehydrogenase and pyruvate dehydrogenase kinase expression in non small cell lung cancer and tumor-associated stromal
MI Koukourakis et al.
NEOPLASIA (2005)
ROS stress in cancer cells and therapeutic implications
H Pelicano et al.
DRUG RESISTANCE UPDATES (2004)
Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP
YH Ko et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
2-deoxy-D-glucose increases the efficacy of adriamycin and paclitaxel in human osteosarcoma and non-small cell lung cancers in vivo
G Maschek et al.
CANCER RESEARCH (2004)
Akt stimulates aerobic glycolysis in cancer cells
RL Elstrom et al.
CANCER RESEARCH (2004)
P-glycoprotein: from genomics to mechanism
SV Ambudkar et al.
ONCOGENE (2003)
SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers
H Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Phase II study of lonidamine and diazepam in the treatment of recurrent glioblastoma multiforme
S Oudard et al.
JOURNAL OF NEURO-ONCOLOGY (2003)
GLUT1 messenger RNA and protein induction relates to the malignant transformation of cervical cancer
C Rudlowski et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2003)
Mechanism of superoxide and hydrogen peroxide formation by fumarate reductase, succinate dehydrogenase, and aspartate oxidase
KR Messner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors
GD Demetri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Changes in MCT 1, MCT 4, and LDH expression are tissue specific in rats after long-term hypobaric hypoxia
GB McClelland et al.
JOURNAL OF APPLIED PHYSIOLOGY (2002)
Mitochondrial binding of hexokinase II inhibits Bax-induced cytochrome c release and apoptosis
JG Pastorino et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the philadelphia chromosome.
BJ Druker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor.
H Joensuu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Paclitaxel, cisplatin and lonidamine in advanced ovarian cancer. A phase II study
M De Lena et al.
EUROPEAN JOURNAL OF CANCER (2001)
Share Paper
